Transparency · The FDA & Research Peptides

Where the FDA stands — and why we operate the way we do

We’d rather be completely open about this than let anyone guess. Here is our honest, fact-based read on how the FDA views research-grade peptides, why that view is reasonable, and how it shapes the way we run this company. If a claim below can’t be sourced, it doesn’t belong here.

Where we stand, plainly: we are pro-FDA, pro-pharmaceutical, and pro-peptide.

Those three positions are not in tension. The FDA’s approval standard exists for good reason, and we would rather it be strict than lenient — it is a large part of why you can trust what sits on a pharmacy shelf. Approved medicines are one of the genuine achievements of modern science, and the researchers and clinicians behind them deserve the credit. Peptides are a real and promising field of study, which is precisely why they deserve rigorous evidence rather than internet folklore.

So nothing on this page is an argument against regulation, and nothing here is a case for self-experimentation. It is an explanation of where research-grade compounds actually sit inside the rules — and why we supply ours for research use only.

For research and educational use only. Nothing on this page is medical, legal, or dosing advice, and nothing here markets any product for human use. It explains the regulatory landscape as we understand it, with sources you can check yourself.

First, what the FDA actually is

The FDA is the Food and Drug Administration — a federal agency inside the Department of Health and Human Services. Its job, under the Federal Food, Drug, and Cosmetic Act, is to protect public health by overseeing food, human and veterinary drugs, biologics, medical devices, cosmetics, tobacco, and radiation-emitting products. [1][2]

A common mix-up: the FDA does not primarily regulate alcohol. Alcoholic beverages fall chiefly under the TTB (Alcohol and Tobacco Tax and Trade Bureau, part of the U.S. Treasury). We mention it because getting the basics right matters — if we’re going to talk about the FDA, we should describe it accurately. [3]

The most important thing to understand: the FDA’s mandate to protect the public isn’t optional or negotiable. That’s the lens for everything below. It is not an agency out to “get” anyone — it is doing the job the law assigns it. [2]

What “FDA approved” really means

This is the piece most people get wrong. FDA approval is not a safety sticker stamped on a molecule. When the FDA approves a drug, it has made an evidence-based judgment that a specific product — a specific manufacturer, formulation, strength, and purity, made under federal manufacturing standards (cGMP) — has been shown to be both safe and effective for a specific, approved use, at a specific dose. [4][5]

It’s a benefit-vs-risk judgment

Approval means the benefits were shown to outweigh the risks for that use — backed by clinical evidence, not just a clean purity report. A pure compound that doesn’t work, or whose risks outweigh its benefits, doesn’t get approved.

It’s tied to a product, not a molecule

The same molecule at a different dose, route, purity, or use is a different regulatory question. Approval attaches to the exact product and label — it does not bless the chemical everywhere it shows up.

So “FDA approved” is a documented standard of evidence and manufacturing — not a blanket seal, and not a formality. That distinction is the whole ballgame for research peptides. [4][5]

Why research-grade peptides aren’t — and won’t be — FDA approved

To become an approved drug, a substance has to run the full pathway: lab and animal testing, an Investigational New Drug filing, human clinical trials (Phase 1 safety → Phase 2 dosing/efficacy → Phase 3 confirmation), and a New Drug or Biologics License Application the FDA reviews. [6] A chemical sold “for research use only” has, by definition, not done that — so it is simply not an approved drug, and can’t lawfully be marketed for human use. [6][7]

People often assume the FDA withholds approval because these compounds “work too well” or someone wants to keep them from you. That’s not the reality. Research-grade peptides simply have no oversight the FDA can stand behind, and many were never developed as drugs at all:

Never submitted

A large share of “research” peptides were only ever studied as lab tools or in animals, and were never taken into human drug development.

Failed or abandoned in trials

Others entered clinical trials and stalled. CJC-1295’s registered Phase 2 program is listed as terminated; davalintide completed a Phase 2 obesity trial and was then discontinued; BPC-157 has no completed controlled human efficacy trial and no approval anywhere. [8][9][10]

The pathway does work

Some peptides did finish the process and are approved drugs — semaglutide and tesamorelin, for example. [11][12] So “peptide” isn’t a synonym for “unapproved.” But a research-grade version of that same molecule, made outside the approved framework, is not the approved drug.

The real issue is oversight — think of a restaurant

Here’s the honest way to see it. Ask yourself whether you’d eat at a restaurant that had no health inspection — no cleanliness standards, no one ever checking the kitchen. Most people wouldn’t. Not because the food is definitely bad, but because nothing independent is verifying that it’s safe.

Restaurants are held to an enforceable, independently inspected standard — local health departments inspect them, largely using the FDA Food Code as the model. [13] Approved drugs work the same way: they’re held to FDA’s evidence and manufacturing standards, and the facilities that make them are inspected. Research-grade material sits outside that system — no independent inspection, no verified identity or purity, no adverse-event monitoring. You’re relying entirely on the seller’s own word.

This isn’t hypothetical. The FDA has actively scrutinized peptide manufacturing and compounding on safety grounds — placing a long list of popular peptides into a “significant safety risks” category during its review, largely because there was so little human safety data behind them. [14] The regulatory status of many peptides remains unsettled and under active FDA review; being under review is not the same as being approved or cleared for human use.

Quick primer: pharmacies can only compound a drug from bulk ingredients under specific legal conditions, and FDA-registered outsourcing facilities must follow cGMP and are FDA-inspected. [15] Most research peptides don’t meet those conditions — which is exactly why they carry no independent quality assurance.

Why our products say “not for human consumption”

That label is not fine print, and it’s not a wink. It’s a legal necessity, and we mean it literally. Under the FD&C Act, a product’s regulatory status is set by its intended use — what it’s marketed and labeled for. Because these peptides were never approved by the FDA for human use, marketing them for human use would turn them into unapproved, misbranded drugs. [7][16]

So when we say for research use only, we’re being accurate about what these products are and are not. The reason they’re not for human consumption is simply that the FDA did not approve them to be used or marketed that way — and we’re not going to pretend otherwise.

And why we’ll never hand out dosing

As peptides have grown in popularity and people have reported real experiences with them, the pressure to give “how much” guidance has only gone up. We don’t, and we won’t — genuinely and rightfully:

We are not medical providers. We’re not diagnosing, treating, or overseeing anyone’s care, and we can’t follow up on your bloodwork or outcomes.
We’re not taking on the clinical risk and liability that comes with telling a person to put something in their body.
These products are intended strictly for research, exactly as their labeling states.

What we can do — and do obsessively — is be transparent about purity, testing, and sourcing, and explain the science honestly so you can understand what you’re working with.

The bottom line

The FDA is doing its job: protecting the public with an evidence-and-inspection standard it can actually stand behind. Research-grade peptides live outside that standard — which is why they’re labeled for research only, why the FDA won’t vouch for them, and why the honest description of this space is that it’s largely unregulated. We think you deserve to hear that plainly.

Our job is to do our part right: verify what we can, document it, stay in our lane, and never oversell. That’s the whole reason this page exists. See exactly how we source and test →

References

FDA — What does FDA regulate? fda.gov
FDA — What We Do (mission; FD&C Act). fda.gov
Alcohol and Tobacco Tax and Trade Bureau (TTB, U.S. Treasury) — jurisdiction over alcoholic beverages. usa.gov
FDA — 10 Facts about What FDA Does and Does Not Approve. fda.gov
FDA — Is It Really ‘FDA Approved’? fda.gov
FDA — Development & Approval Process (Drugs) (IND → Phases 1–3 → NDA/BLA). fda.gov
FD&C Act §505 / 21 U.S.C. §355 (new-drug approval; unapproved new drugs). govinfo.gov
ClinicalTrials.gov — NCT00267527, CJC-1295 Phase 2 (ConjuChem), status Terminated. clinicaltrials.gov
ClinicalTrials.gov — NCT00785408, davalintide Phase 2 (Amylin), completed then discontinued. clinicaltrials.gov
DoD Operation Supplement Safety — BPC-157: A Prohibited Peptide and an Unapproved Drug. opss.org
FDA — Egrifta SV (tesamorelin) prescribing information, NDA 022505. accessdata.fda.gov
FDA — Ozempic (semaglutide) label & approval. Drugs@FDA
FDA — FDA Food Code (model code adopted/enforced by state & local health departments). fda.gov
FDA — Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (“Category 2”). fda.gov
FDA — Human Drug Compounding (503A vs 503B; outsourcing facilities follow cGMP and are FDA-inspected). fda.gov
FDA — Laws Enforced by FDA (FD&C Act; misbranding §502; intended use). fda.gov

This page is educational and reflects our understanding of federal regulation at the time of writing; regulations change. It is not legal advice. For research and educational use only.

For research and educational use only. Not medical, legal, or dosing advice, and not an offer of any product for human use.